Wei Jiang

SAIC-GM (China)

Health Outcomes Studied

• Improved Gut Microbiota

Papers (3)

• 2026
  The enhancing therapeutic effect of neonatal jaundice by bifidobacterium through regulating inflammation and gut microbiota in combination with phototherapy-a randomized controlled trial.10.3389/fmicb.2026.1761245
• 2026
  Bifidobacterium animalis subsp. lactis BLa80 for preventing allergic, respiratory, and gastrointestinal diseases in young children in China: a randomized double-blind placebo-controlled trial.10.3345/cep.2025.01256
• 2025
  <i>Bifidobacterium longum</i> subsp. <i>longum</i> dipro-O: a potential therapeutic agent for ameliorating metabolic disorders in high-fat diet-induced obesity mouse model.10.3389/fendo.2025.1519058